By Ian Quinn2025-10-01T14:29:00
Chris Whitty said the lack of data about the booming GLP-1 category of drugs meant they should only be prioritised as a solution for people with morbid obesity problems
Chief medical officer Chris Whitty has warned the government against a mass shift to the use of weight-loss drugs to tackle the obesity crisis, saying there is a lack of long-term evidence over their safety and effectiveness.
Already have an account? Sign in here
Already have an account? Sign in here